Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Industry Trends Analysis Report By Modality (Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging), By Country and Growth Forecast, 2022 - 2

Europe Coronary Heart Disease Diagnostic Imaging Devices Market Size, Share & Industry Trends Analysis Report By Modality (Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging), By Country and Growth Forecast, 2022 - 2028

The Europe Coronary Heart Disease Diagnostic Imaging Devices Market would witness market growth of 6.3% CAGR during the forecast period (2022-2028).

CAD is the most common type of heart disease, according to the Centers for Disease Control and Prevention (CDC). According to the Centers for Disease Control and Prevention (CDC), a significant proportion of the worldwide population dies from coronary artery disease every year. According to the American Heart Association (AHA), coronary artery disease kills the majority of those in their geriatric age.

The rising prevalence of coronary artery disease is driving the coronary artery imaging market. Coronary artery disease is a leading cause of death in various countries. The market for coronary artery imaging handles issues, such as diagnosis. In these fields, there is a great demand for high resolution, label-free, rapid, and in vivo imaging techniques. The market for coronary artery imaging is expected to grow due to rising rates of coronary artery disease and a geriatric population. Moreover, the market is also estimated to rise due to the increasing demand for CT and MRI.

In the European Union, cardiovascular disorders are the major cause of death. They refer to a wide range of medical conditions that affect the circulatory system (heart and blood vessels) and are frequently caused by atherosclerosis, which is the abnormal build-up of plaque (which can include cholesterol or fatty substances) on the interior walls of a person's arteries. Ischemic heart disease (heart attacks), as well as cerebrovascular illnesses, is two of the most frequent circulatory system diseases (strokes). Moreover, several EU Member States have witnessed a decrease in the number of deaths related to circulatory system disorders in recent years. These changes could have occurred, at least in part, as a result of enhanced screening and novel surgical methods, as well as new types of medication and patient lifestyle modifications.

The Germany market dominated the Europe Coronary Heart Disease Diagnostic Imaging Devices Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $147.2 Million by 2028. The UK market is estimated to grow at a CAGR of 5.4% during (2022 - 2028). Additionally, The France market would witness a CAGR of 7.1% during (2022 - 2028).

Based on Modality, the market is segmented into Nuclear Medicine, Computed Tomography, Ultrasound, X rays, and Magnetic Resonance Imaging. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co. (GE Healthcare), Koninklijke Philips N.V., Siemens Healthineers AG, Fujifilm Holdings Corporation, Canon, Inc. (Canon Medical Systems Corporation), Mindray Medical International Limited, Chison Medical Technologies Co., Ltd., and Analogic Corporation (Altaris Capital Partners).

Scope of the Study

Market Segments covered in the Report:

By Modality

  • Nuclear Medicine
  • Computed Tomography
  • Ultrasound
  • X rays
  • Magnetic Resonance Imaging
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
Companies Profiled
  • General Electric (GE) Co. (GE Healthcare)
  • Koninklijke Philips N.V.
  • Siemens Healthineers AG
  • Fujifilm Holdings Corporation
  • Canon, Inc. (Canon Medical Systems Corporation)
  • Mindray Medical International Limited
  • Chison Medical Technologies Co., Ltd.
  • Analogic Corporation (Altaris Capital Partners)
Unique Offerings from KBV Research
  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free


Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Coronary Heart Disease Diagnostic Imaging Devices Market, by Modality
1.4.2 Europe Coronary Heart Disease Diagnostic Imaging Devices Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Approvals and Trials
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions : 2018, Mar – 2022, Feb) Leading Players
Chapter 4. Europe Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
4.1 Europe Nuclear Medicine Market by Country
4.2 Europe Computed Tomography Market by Country
4.3 Europe Ultrasound Market by Country
4.4 Europe X rays Market by Country
4.5 Europe Magnetic Resonance Imaging Market by Country
Chapter 5. Europe Coronary Heart Disease Diagnostic Imaging Devices Market by Country
5.1 Germany Coronary Heart Disease Diagnostic Imaging Devices Market
5.1.1 Germany Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.2 UK Coronary Heart Disease Diagnostic Imaging Devices Market
5.2.1 UK Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.3 France Coronary Heart Disease Diagnostic Imaging Devices Market
5.3.1 France Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.4 Russia Coronary Heart Disease Diagnostic Imaging Devices Market
5.4.1 Russia Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.5 Spain Coronary Heart Disease Diagnostic Imaging Devices Market
5.5.1 Spain Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.6 Italy Coronary Heart Disease Diagnostic Imaging Devices Market
5.6.1 Italy Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
5.7 Rest of Europe Coronary Heart Disease Diagnostic Imaging Devices Market
5.7.1 Rest of Europe Coronary Heart Disease Diagnostic Imaging Devices Market by Modality
Chapter 6. Company Profiles
6.1 General Electric (GE) Co. (GE Healthcare)
6.1.1 Company Overview
6.1.1 Financial Analysis
6.1.2 Segmental and Regional Analysis
6.1.3 Research & Development Expense
6.1.4 Recent Strategies and Developments:
6.1.4.1 Partnerships, Collaborations and Agreements:
6.1.4.2 Approvals and Trials:
6.1.5 SWOT Analysis
6.2 Koninklijke Philips N.V.
6.2.1 Company Overview
6.2.2 Financial Analysis
6.2.3 Segmental and Regional Analysis
6.2.4 Research & Development Expense
6.2.5 Recent Strategies and Developments:
6.2.5.1 Partnerships, Collaborations and Agreements:
6.2.5.2 Acquisitions and Mergers:
6.3 Siemens Healthineers AG (Siemens AG)
6.3.1 Company Overview
6.3.2 Financial Analysis
6.3.3 Segmental and Regional Analysis
6.3.4 Research & Development Expense
6.3.5 Recent Strategies and Developments:
6.3.5.1 Product Launches and Product Expansions:
6.4 Fujifilm Holdings Corporation
6.4.1 Company Overview
6.4.2 Financial Analysis
6.4.4 Research & Development Expenses
6.4.5 Recent Strategies and Developments:
6.4.5.1 Product Launches and Product Expansions:
6.5 Canon, Inc. (Canon Medical Systems Corporation)
6.5.1 Company Overview
6.5.2 Financial Analysis
6.5.3 Segmental and Regional Analysis
6.5.5 Recent strategies and developments:
6.5.5.1 Partnerships, Collaborations, and Agreements:
6.5.5.2 Product Launches and Product Expansions:
6.6 Mindray Medical International Limited
6.6.1 Company Overview
6.6.2 Recent strategies and developments:
6.6.2.1 Product Launches and Product Expansions:
6.7 Chison Medical Technologies Co., Ltd.
6.7.1 Company Overview
6.8 Analogic Corporation (Altaris Capital Partners)
6.8.1 Company Overview

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings